198 related articles for article (PubMed ID: 26573835)
1. Activation of the Aryl Hydrocarbon Receptor by 10-Cl-BBQ Prevents Insulitis and Effector T Cell Development Independently of Foxp3+ Regulatory T Cells in Nonobese Diabetic Mice.
Ehrlich AK; Pennington JM; Wang X; Rohlman D; Punj S; Löhr CV; Newman MT; Kolluri SK; Kerkvliet NI
J Immunol; 2016 Jan; 196(1):264-73. PubMed ID: 26573835
[TBL] [Abstract][Full Text] [Related]
2. Benzimidazoisoquinolines: a new class of rapidly metabolized aryl hydrocarbon receptor (AhR) ligands that induce AhR-dependent Tregs and prevent murine graft-versus-host disease.
Punj S; Kopparapu P; Jang HS; Phillips JL; Pennington J; Rohlman D; O'Donnell E; Iversen PL; Kolluri SK; Kerkvliet NI
PLoS One; 2014; 9(2):e88726. PubMed ID: 24586378
[TBL] [Abstract][Full Text] [Related]
3. Activation of aryl hydrocarbon receptor by TCDD prevents diabetes in NOD mice and increases Foxp3+ T cells in pancreatic lymph nodes.
Kerkvliet NI; Steppan LB; Vorachek W; Oda S; Farrer D; Wong CP; Pham D; Mourich DV
Immunotherapy; 2009 Jul; 1(4):539-47. PubMed ID: 20174617
[TBL] [Abstract][Full Text] [Related]
4. Dietary Indole-3-Carbinol Activates AhR in the Gut, Alters Th17-Microbe Interactions, and Exacerbates Insulitis in NOD Mice.
Kahalehili HM; Newman NK; Pennington JM; Kolluri SK; Kerkvliet NI; Shulzhenko N; Morgun A; Ehrlich AK
Front Immunol; 2020; 11():606441. PubMed ID: 33552063
[TBL] [Abstract][Full Text] [Related]
5. Activation of the aryl hydrocarbon receptor inhibits neuropilin-1 upregulation on IL-2-responding CD4
Sandoval S; Malany K; Thongphanh K; Martinez CA; Goodson ML; Souza FDC; Lin LW; Sweeney N; Pennington J; Lein PJ; Kerkvliet NI; Ehrlich AK
Front Immunol; 2023; 14():1193535. PubMed ID: 38035105
[TBL] [Abstract][Full Text] [Related]
6. IL-33 Prevents MLD-STZ Induction of Diabetes and Attenuate Insulitis in Prediabetic NOD Mice.
Pavlovic S; Petrovic I; Jovicic N; Ljujic B; Miletic Kovacevic M; Arsenijevic N; Lukic ML
Front Immunol; 2018; 9():2646. PubMed ID: 30498495
[TBL] [Abstract][Full Text] [Related]
7. Activation of aryl hydrocarbon receptor (AhR) leads to reciprocal epigenetic regulation of FoxP3 and IL-17 expression and amelioration of experimental colitis.
Singh NP; Singh UP; Singh B; Price RL; Nagarkatti M; Nagarkatti PS
PLoS One; 2011; 6(8):e23522. PubMed ID: 21858153
[TBL] [Abstract][Full Text] [Related]
8. A Novel Liposome Formulation Carrying Both an Insulin Peptide and a Ligand for Invariant Natural Killer T Cells Induces Accumulation of Regulatory T Cells to Islets in Nonobese Diabetic Mice.
Akimoto H; Fukuda-Kawaguchi E; Duramad O; Ishii Y; Tanabe K
J Diabetes Res; 2019; 2019():9430473. PubMed ID: 31781669
[TBL] [Abstract][Full Text] [Related]
9. AhR Ligands Differentially Regulate miRNA-132 Which Targets HMGB1 and to Control the Differentiation of Tregs and Th-17 Cells During Delayed-Type Hypersensitivity Response.
Abdulla OA; Neamah W; Sultan M; Chatterjee S; Singh N; Nagarkatti M; Nagarkatti P
Front Immunol; 2021; 12():635903. PubMed ID: 33679792
[TBL] [Abstract][Full Text] [Related]
10. RORγt Promotes Foxp3 Expression by Antagonizing the Effector Program in Colonic Regulatory T Cells.
Bhaumik S; Mickael ME; Moran M; Spell M; Basu R
J Immunol; 2021 Oct; 207(8):2027-2038. PubMed ID: 34518282
[TBL] [Abstract][Full Text] [Related]
11. β-cell-specific IL-2 therapy increases islet Foxp3+Treg and suppresses type 1 diabetes in NOD mice.
Johnson MC; Garland AL; Nicolson SC; Li C; Samulski RJ; Wang B; Tisch R
Diabetes; 2013 Nov; 62(11):3775-84. PubMed ID: 23884888
[TBL] [Abstract][Full Text] [Related]
12. Endogenous expansion of regulatory T cells leads to long-term islet graft survival in diabetic NOD mice.
Shi Q; Lees JR; Scott DW; Farber DL; Bartlett ST
Am J Transplant; 2012 May; 12(5):1124-32. PubMed ID: 22299822
[TBL] [Abstract][Full Text] [Related]
13. Effects of a germ-free environment on gut immune regulation and diabetes progression in non-obese diabetic (NOD) mice.
Alam C; Bittoun E; Bhagwat D; Valkonen S; Saari A; Jaakkola U; Eerola E; Huovinen P; Hänninen A
Diabetologia; 2011 Jun; 54(6):1398-406. PubMed ID: 21380595
[TBL] [Abstract][Full Text] [Related]
14. Reduced IL-2 expression in NOD mice leads to a temporal increase in CD62Llo FoxP3+ CD4+ T cells with limited suppressor activity.
Goudy KS; Johnson MC; Garland A; Li C; Samulski RJ; Wang B; Tisch R
Eur J Immunol; 2011 May; 41(5):1480-1490. PubMed ID: 21469091
[TBL] [Abstract][Full Text] [Related]
15. Dietary Indoles Suppress Delayed-Type Hypersensitivity by Inducing a Switch from Proinflammatory Th17 Cells to Anti-Inflammatory Regulatory T Cells through Regulation of MicroRNA.
Singh NP; Singh UP; Rouse M; Zhang J; Chatterjee S; Nagarkatti PS; Nagarkatti M
J Immunol; 2016 Feb; 196(3):1108-22. PubMed ID: 26712945
[TBL] [Abstract][Full Text] [Related]
16. Dendritic cell-expanded, islet-specific CD4+ CD25+ CD62L+ regulatory T cells restore normoglycemia in diabetic NOD mice.
Tarbell KV; Petit L; Zuo X; Toy P; Luo X; Mqadmi A; Yang H; Suthanthiran M; Mojsov S; Steinman RM
J Exp Med; 2007 Jan; 204(1):191-201. PubMed ID: 17210729
[TBL] [Abstract][Full Text] [Related]
17. TCDD, FICZ, and Other High Affinity AhR Ligands Dose-Dependently Determine the Fate of CD4+ T Cell Differentiation.
Ehrlich AK; Pennington JM; Bisson WH; Kolluri SK; Kerkvliet NI
Toxicol Sci; 2018 Feb; 161(2):310-320. PubMed ID: 29040756
[TBL] [Abstract][Full Text] [Related]
18. Cyclophosphamide-induced type-1 diabetes in the NOD mouse is associated with a reduction of CD4+CD25+Foxp3+ regulatory T cells.
Brode S; Raine T; Zaccone P; Cooke A
J Immunol; 2006 Nov; 177(10):6603-12. PubMed ID: 17082572
[TBL] [Abstract][Full Text] [Related]
19. 11-Cl-BBQ, a select modulator of AhR-regulated transcription, suppresses lung cancer cell growth via activation of p53 and p27
Nguyen BD; Stevens BL; Elson DJ; Finlay D; Gamble JT; Kopparapu PR; Tanguay RL; Buermeyer AB; Kerkvliet NI; Kolluri SK
FEBS J; 2023 Apr; 290(8):2064-2084. PubMed ID: 36401795
[TBL] [Abstract][Full Text] [Related]
20. Pancreas-infiltrating Th1 cells and diabetes develop in IL-12-deficient nonobese diabetic mice.
Trembleau S; Penna G; Gregori S; Chapman HD; Serreze DV; Magram J; Adorini L
J Immunol; 1999 Sep; 163(5):2960-8. PubMed ID: 10453045
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]